miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow
Background. Coronary slow flow (CSF) refers to the phenomenon of delayed distal flow in the absence of lesions detected on coronary angiography. Although the detection rate of CSF has been increasing in clinical practice, early diagnosis is difficult and the factors contributing to this condition re...
Main Authors: | Tong Chen, Zhen-Yu Wang, Chuan-Chang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2020/7490942 |
Similar Items
-
Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow
by: Qiang Su, et al.
Published: (2018-01-01) -
Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
by: Yuan-Ting Zhu, et al.
Published: (2020-01-01) -
The Association between Inflammatory Cytokines and miRNAs with Slow Coronary Flow Phenomenon
by: Shahla Danaii, et al.
Published: (2020-02-01) -
miRNA-146a and miRNA-126 as Potential Biomarkers in Patients with Coronary Artery Disease and Generalized Periodontitis
by: Jaideep Mahendra, et al.
Published: (2021-08-01) -
Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach
by: Kumkum Kar, et al.
Published: (2021-01-01)